1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Tuberculosis Diagnostics Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Tuberculosis Diagnostics Market Revenues & Volume, 2022 & 2032F |
3.3 United States (US) Tuberculosis Diagnostics Market - Industry Life Cycle |
3.4 United States (US) Tuberculosis Diagnostics Market - Porter's Five Forces |
3.5 United States (US) Tuberculosis Diagnostics Market Revenues & Volume Share, By Test Type, 2022 & 2032F |
3.6 United States (US) Tuberculosis Diagnostics Market Revenues & Volume Share, By End-use, 2022 & 2032F |
4 United States (US) Tuberculosis Diagnostics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of tuberculosis in the United States |
4.2.2 Rising awareness about early diagnosis and treatment of tuberculosis |
4.2.3 Technological advancements in diagnostic tools for tuberculosis detection |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of tuberculosis diagnostics |
4.3.2 High cost associated with advanced tuberculosis diagnostic tests |
4.3.3 Limited access to healthcare facilities in certain regions of the United States |
5 United States (US) Tuberculosis Diagnostics Market Trends |
6 United States (US) Tuberculosis Diagnostics Market, By Types |
6.1 United States (US) Tuberculosis Diagnostics Market, By Test Type |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Tuberculosis Diagnostics Market Revenues & Volume, By Test Type, 2022-2032F |
6.1.3 United States (US) Tuberculosis Diagnostics Market Revenues & Volume, By Radiographic Method, 2022-2032F |
6.1.4 United States (US) Tuberculosis Diagnostics Market Revenues & Volume, By Diagnostic Laboratory Methods, 2022-2032F |
6.1.5 United States (US) Tuberculosis Diagnostics Market Revenues & Volume, By Nucleic Acid Testing, 2022-2032F |
6.1.6 United States (US) Tuberculosis Diagnostics Market Revenues & Volume, By Phage Assay, 2022-2032F |
6.1.7 United States (US) Tuberculosis Diagnostics Market Revenues & Volume, By Detection of Latent Infection (Skin Test & IGRA), 2022-2032F |
6.1.8 United States (US) Tuberculosis Diagnostics Market Revenues & Volume, By Cytokine Detection Assay, 2022-2032F |
6.2 United States (US) Tuberculosis Diagnostics Market, By End-use |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Tuberculosis Diagnostics Market Revenues & Volume, By Diagnostic Laboratories, 2022-2032F |
6.2.3 United States (US) Tuberculosis Diagnostics Market Revenues & Volume, By Hospitals & Clinics, 2022-2032F |
7 United States (US) Tuberculosis Diagnostics Market Import-Export Trade Statistics |
7.1 United States (US) Tuberculosis Diagnostics Market Export to Major Countries |
7.2 United States (US) Tuberculosis Diagnostics Market Imports from Major Countries |
8 United States (US) Tuberculosis Diagnostics Market Key Performance Indicators |
8.1 Percentage increase in the adoption rate of new tuberculosis diagnostic technologies |
8.2 Average waiting time for tuberculosis test results |
8.3 Number of public health campaigns promoting tuberculosis awareness in the United States |
8.4 Rate of successful treatment outcomes for tuberculosis patients |
8.5 Percentage of healthcare facilities offering tuberculosis diagnostic services |
9 United States (US) Tuberculosis Diagnostics Market - Opportunity Assessment |
9.1 United States (US) Tuberculosis Diagnostics Market Opportunity Assessment, By Test Type, 2022 & 2032F |
9.2 United States (US) Tuberculosis Diagnostics Market Opportunity Assessment, By End-use, 2022 & 2032F |
10 United States (US) Tuberculosis Diagnostics Market - Competitive Landscape |
10.1 United States (US) Tuberculosis Diagnostics Market Revenue Share, By Companies, 2025 |
10.2 United States (US) Tuberculosis Diagnostics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |